UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
SAE technical paper series, Volume 2013-24-0028.
eJournal
SAE technical paper series, Volume 2013-24-0028.
eJournal
Combustion and flame, ISSN 0010-2180, 08/2017, Volume 182, Issue C, pp. 150 - 166
Ethane | Ignition | Reaction kinetics | High pressure | Library approved | HIGH-TEMPERATURE OXIDATION | LAMINAR FLAME SPEEDS | ELEMENTARY REACTIONS | ELEVATED PRESSURES | REFLECTED SHOCK-WAVES | RAPID COMPRESSION MACHINE | IGNITION DELAY TIMES | OXYGEN-ARGON MIXTURES | To be checked by Faculty | RATE CONSTANTS | MASTER EQUATION | Oxidation-reduction reaction | Chemical reaction, Rate of | Analysis | Force and energy | Potential energy | Rate constants | Laminar flow | Thermal dissociation | Chain branching | Oxidation | Mathematical models | Modelling | Pressure | INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY | ethane | reaction kinetics | ignition | high pressure
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2124 - 2130
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Gastrointestinal Neoplasms - mortality | Humans | Middle Aged | Male | Gastrointestinal Neoplasms - pathology | Time Factors | Myelodysplastic Syndromes - chemically induced | Neuroendocrine Tumors - diagnostic imaging | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Pancreatic Neoplasms - mortality | Neuroendocrine Tumors - pathology | Severity of Illness Index | Hematologic Diseases - chemically induced | Octreotide - analogs & derivatives | Risk Assessment | Organometallic Compounds - adverse effects | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Carcinoid Tumor - diagnostic imaging | Octreotide - adverse effects | Logistic Models | Treatment Outcome | Octreotide - therapeutic use | Carcinoid Tumor - pathology | Disease-Free Survival | Gastrointestinal Neoplasms - diagnostic imaging | Neuroendocrine Tumors - mortality | Radionuclide Imaging | Aged | Chemical and Drug Induced Liver Injury | Radiopharmaceuticals - adverse effects | Carcinoid Tumor - mortality | Pancreatic Neoplasms - diagnostic imaging | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Nature reviews. Endocrinology, ISSN 1759-5029, 02/2014, Volume 10, Issue 2, pp. 102 - 114
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Pancreatic Neoplasms - diagnosis | Humans | Tomography, Emission-Computed, Single-Photon | Tomography, X-Ray Computed | Treatment Outcome | Neuroendocrine Tumors - diagnosis | Positron-Emission Tomography | Diagnostic Imaging - methods | Pancreatic Neoplasms - drug therapy | Magnetic Resonance Imaging | Neuroendocrine Tumors - drug therapy | Intestinal Neoplasms - diagnosis | Radiopharmaceuticals | Intestinal Neoplasms - drug therapy | CT imaging | Health aspects | Usage | Index Medicus
Journal Article
The Journal of nuclear medicine (1978), ISSN 0161-5505, 10/2019, Volume 60, Issue 10, pp. 1406 - 1413
Dosimeters | Vertebrae | Images | Vertebra | Thorax | Metastasis | Injection | Patients | Single photon emission computed tomography | Metastases | Lutetium isotopes | Correlation analysis | Compartments | Bone marrow | Dosimetry | Platelets | Methods | Tumors | Neuroendocrine tumors | Index Medicus
Journal Article
The Journal of nuclear medicine (1978), ISSN 0161-5505, 09/2011, Volume 52, Issue 9, pp. 1361 - 1368
Health-related quality of life | Gastroenteropancreatic neuroendocrine tumor | octreotate | Lu-DOTA | Bronchial neuroendocrine tumor | Tyr | Peptide receptor radionuclide therapy | Quality of life | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Pain - epidemiology | Humans | Male | Anorexia - psychology | Karnofsky Performance Status | Social Behavior | Organometallic Compounds - therapeutic use | Female | Surveys and Questionnaires | Quality of Life - psychology | Emotions - physiology | Stomach Neoplasms - radiotherapy | Data Interpretation, Statistical | Stomach Neoplasms - psychology | Neoplasm Metastasis - radiotherapy | Octreotide - analogs & derivatives | Organometallic Compounds - adverse effects | Octreotide - adverse effects | Pancreatic Neoplasms - radiotherapy | Treatment Outcome | Octreotide - therapeutic use | Disease Progression | Neuroendocrine Tumors - radiotherapy | Pain - psychology | Neuroendocrine Tumors - psychology | Pancreatic Neoplasms - psychology | Radiopharmaceuticals - adverse effects | Health Status | Radiopharmaceuticals - therapeutic use | Medical treatment | Cancer | Tumors | Index Medicus
Journal Article
Energy & fuels, ISSN 0887-0624, 03/2017, Volume 31, Issue 3, pp. 2175 - 2182
Journal Article
Endocrine-related cancer, ISSN 1351-0088, 3/2010, Volume 17, Issue 1, pp. R53 - R73
Review | Oncology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Humans | Digestive System Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - pharmacokinetics | Octreotide - pharmacokinetics | Digestive System Neoplasms - drug therapy | Gallium Radioisotopes - therapeutic use | Digestive System Neoplasms - diagnostic imaging | Neuroendocrine Tumors - diagnostic imaging | Receptors, Somatostatin - analysis | Organometallic Compounds - therapeutic use | Yttrium Radioisotopes - therapeutic use | Somatostatin - analogs & derivatives | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Indium Radioisotopes - pharmacokinetics | Positron-Emission Tomography - methods | Octreotide - therapeutic use | Somatostatin - pharmacokinetics | Peptides, Cyclic - pharmacokinetics | Neuroendocrine Tumors - radiotherapy | Animals | Organotechnetium Compounds - pharmacokinetics | Positron-Emission Tomography - standards | Receptors, Somatostatin - drug effects | Gallium Radioisotopes - pharmacokinetics | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Quality of Life | Indium Radioisotopes - therapeutic use | Somatostatin - therapeutic use | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
BMJ (Online), ISSN 0959-8146, 2016, Volume 354, p. i3625
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Male | Renal Insufficiency, Chronic - complications | Sulfonylurea Compounds - adverse effects | Metformin - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Diabetic Nephropathies - complications | Renal Insufficiency, Chronic - epidemiology | Young Adult | Hypoglycemic Agents | England - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Diabetic Nephropathies - epidemiology | Sulfonylurea Compounds - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemia - chemically induced | Cohort Studies
Journal Article
SAE International journal of fuels and lubricants, ISSN 1946-3952, 11/2016, Volume 9, Issue 3, pp. 695 - 702
Journal Article
Nature reviews. Endocrinology, ISSN 1759-5029, 07/2009, Volume 5, Issue 7, pp. 382 - 393
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Neuroendocrine Tumors - radiotherapy | Somatostatin - analogs & derivatives | Radioisotopes - therapeutic use | Octreotide - analogs & derivatives | Receptors, Peptide - therapeutic use | Humans | Somatostatin - therapeutic use | Octreotide - therapeutic use | Radiopharmaceuticals - therapeutic use | Receptors, Peptide - metabolism | Endocrine gland cancer | Care and treatment | Diagnosis | Research | Somatostatin | Radiotherapy | Health aspects | Index Medicus
Journal Article